KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nektar Therapeutics (NKTR) Other Operating Expenses (2016 - 2025)

Nektar Therapeutics has reported Other Operating Expenses over the past 16 years, most recently at $8.6 million for Q4 2025.

  • Quarterly results put Other Operating Expenses at $8.6 million for Q4 2025, down 93.22% from a year ago — trailing twelve months through Dec 2025 was -$84.5 million (down 1516.26% YoY), and the annual figure for FY2025 was $9.3 million, up 56.4%.
  • Other Operating Expenses for Q4 2025 was $8.6 million at Nektar Therapeutics, up from $140000.0 in the prior quarter.
  • Over the last five years, Other Operating Expenses for NKTR hit a ceiling of $126.5 million in Q4 2024 and a floor of -$50.4 million in Q1 2025.
  • Median Other Operating Expenses over the past 5 years was $6.9 million (2021), compared with a mean of $11.0 million.
  • Biggest five-year swings in Other Operating Expenses: soared 1840.85% in 2023 and later plummeted 310.08% in 2024.
  • Nektar Therapeutics' Other Operating Expenses stood at $6.2 million in 2021, then soared by 144.33% to $15.1 million in 2022, then tumbled by 45.23% to $8.2 million in 2023, then soared by 1433.79% to $126.5 million in 2024, then plummeted by 93.22% to $8.6 million in 2025.
  • The last three reported values for Other Operating Expenses were $8.6 million (Q4 2025), $140000.0 (Q3 2025), and -$42.8 million (Q2 2025) per Business Quant data.